Abstract:Abstract Background Leukocyte telomere length, as an emerging marker of biological age, has been shown to associate with hypertension. However, it has not been studied whether telomere attrition rate in patients with hypertension is related to the heterogeneity of blood pressure (BP) response to antihypertensive therapy. Purpose Our aim is to investigate the relationship between telomere attrition rate and BP lowering in a longitudinal Chinese hypertensive cohort. We also aim to explore the potential association between telomere attrition rate and the differences in antihypertensive treatment response. Methods A community-based, prospective study was conducted at BenXi county, Liaoning province, in the northern China. A total of 3,671 hypertensive patients were recruited from 2013 t 2015 and of whom 1,382 provided blood samples at baseline. After a median follow-up period of 2.2 (range 1.5–2.4) years, the blood samples were collected from 1,197 patients again in 2016, and 185 patients were not reached to obtain blood sample because of immigration. In addition, 89 blood samples were excluded due to insufficient quality. Finally, 1,108 patients who are available for blood samples both at baseline and at follow-up, were included in the analysis for telomeres change. Annual telomere attrition rate was calculated as (follow-up telomere length-baseline telomere length)/follow-up year, and then categorized into two groups: the shorten (annual telomere attrition rate <0) and the lengthen (annual telomere attrition rate >0). Multivariable linear regression model was used to examine the association of annual telomere attrition rate with blood pressure lowering and antihypertensive treatment. Cox Proportional Hazards model was used to examine the association between annual telomere attrition rate and cardiovascular disease risk. Results In multivariable linear regression models, the telomere lengthening was significantly associated with decrease in systolic blood pressure (SBP) (β: −4.13; p=0.006) and pulse pressure (PP) (β: −3.22; p=0.007) during the follow-up, but not associated with diastolic blood pressure (DBP) change. And the associations were observed age- and gender-specific difference. The lengthen was significantly associated with ΔSBP and ΔPP in women and younger patients (age ≤60 years old). Furthermore, the associations were observed in patients who treated with calcium channel blocker (CCB) and angiotensin receptor blocker (ARB), but not in diuretics. Then we found no significant association between annual telomere attrition rate and incident cardiovascular events during the follow-up. Conclusion(s) Our data showed that the increasing of leukocyte telomere length is associated with the decreasing of SBP and PP, particularly for the patients who received CCB and ARB therapy. These data showed that annual telomere attrition rate could be a marker of treatment response and will help in clinical management. Acknowledgement/Funding the National Science and Technology Pillar Program during the Twelfth Five-year Plan Period (No. 2011BAI11B04)

Longitudinal Association of Telomere Attrition with the Effects of Antihypertensive Treatment and Blood Pressure Lowering

P1693The Longitudinal Associations Between Telomere Attrition and the Effects of Blood Pressure Lowering and Antihypertensive Treatment

Short Telomeres and Prognosis of Hypertension in a Chinese Population.

Shorter Leukocyte Telomere Length Is Associated with Increased Major Adverse Cardiovascular Events or Mortality in Patients with Essential Hypertension

Longitudinal Change in Blood Pressure is Associated with Cardiovascular Disease Mortality in a Chinese Cohort.

17-Year Follow-Up of Association Between Telomere Length and All-Cause Mortality, Cardiovascular Mortality in Individuals with Metabolic Syndrome: Results from the NHANES Database Prospective Cohort Study

Hypertension Control Is Associated with Telomere Length in Older Adults

PS-B09-4: SHORTER LEUKOCYTE TELOMERE LENGTH AS AN EARLY INDICATOR FOR CHRONIC KIDNEY DISEASE IN HYPERTENSIVE PATIENTS

Association between telomere length and blood pressure among different nutritional status children

Baseline and Longitudinal Change in Blood Pressure and Mortality in a Chinese Cohort

Telomere Shortening in Patients on Long-Term Hemodialysis.

Mediating effect of telomere length in a hypertension population exposed to cadmium: a case-control study

Tumor Necrosis Factor-Alpha Mediates the Negative Association Between Telomere Length and Kidney Dysfunction.

Persistent Dyslipidemia Increases the Longitudinal Changes in Telomere Length

Less Than Ideal Cardiovascular Health is Associated with Shorter Leukocyte Telomere Length: the National Health and Nutrition Examination Surveys, 1999–2002

Effect of Vegetable Consumption on the Association Between Peripheral Leucocyte Telomere Length and Hypertension: a Case-Control Study

Leukocyte Telomere Length Predicts Progression From Paroxysmal to Persistent Atrial Fibrillation in the Long Term After Catheter Ablation

Dynamics of leukocyte telomere length in adults aged 50 and older: a longitudinal population-based cohort study

Precision Measurement of Telomere Length as a Future Guide to Improve CVD Interventions

The Association between Leucocyte Telomere Length and Survival Outcomes in Patients with Cardiovascular Disease

Telomere Length and Biological Aging in Atherosclerosis